Ligand– tag –
-
Revolutionizing Drug Delivery: A Comprehensive Review of Polymeric Nanoparticles
Nanbiosis Spain Overview A recent review from Nanbiosis highlights polymeric nanoparticles (PNPs) as cornerstone platforms in nanomedicine, revolutionizing drug delivery, gene therapy, and medical imaging. By precisely engineering proper... -
Gold Nanoparticles Revolutionize Prostate Cancer Treatment: Integrating Targeted Drug Delivery, Photothermal Therapy, and Multimodal Imaging
MDPI Switzerland Overview Gold nanoparticles (AuNPs) are emerging as promising multifunctional nanoplatforms for prostate cancer treatment, leveraging their tunable size, shape, surface plasmon resonance (SPR) properties, and high surfac... -
Precision Lipid Nanoparticles Target Solid Tumors, Spare Healthy Tissue; University of Tokyo System Achieves 10x Concentration
KU Leuven Belgium Overview Researchers at Belgium's Leuven University have engineered novel lipid nanoparticles (LNPs) for targeted chemotherapy in solid tumors. These LNPs selectively bind to protein markers on malignant cells, preventi... -
Korro Bio Accelerates RNA Editing Platform into Clinic with First-in-Human Trial for Hyperammonemia and Designation of AATD Candidate
GlobeNewswire (via Korro Bio, Inc.) USA Overview Korro Bio has announced plans to initiate first-in-human clinical trials for its hyperammonemia treatment candidate, KRRO-121, in late 2026. Concurrently, the company designated KRRO-111 a... -
Alector Advances ‘Brain Carrier’ Platform: Optimizing Brain Drug Delivery via Transferrin Receptor Targeting with Enhanced Safety
Alector USA Overview Alector recently announced significant progress with its proprietary Alector Brain Carrier (ABC) blood-brain barrier (BBB) platform, designed to substantially enhance the delivery of therapeutic agents to the brain. ... -
Nanomedicine Conquers Glioblastoma’s Blood-Brain Barrier: Revolutionizing Treatment via Targeted Delivery, Stimuli-Responsiveness, and AI
Drug Target Review UK Overview Nanomedicine is emerging as a critical solution to overcome the formidable blood-brain barrier (BBB) in treating glioblastoma (GBM), the most aggressive brain tumor. Researchers are developing advanced nano... -
Comprehensive Guide Published: RNA Therapeutics, from ASO to LNP/GalNAc Platforms, Shaping the Future of Precision Medicine
MDPI International Overview A comprehensive guide published by MDPI overviews the engineering history of RNA therapeutics, spanning from ASOs to modern siRNA and mRNA-LNP-based therapies. It highlights a growing regulatory trend favoring... -
Dual-Targeting Lipid Nanoparticles Drastically Enhance β Cell-Specific RNA Delivery, Promising for Type 1 Diabetes Therapy
ACS Publications USA Overview Researchers have developed a dual-targeting lipid nanoparticle (LNP) engineering strategy that significantly enhances β cell-directed RNA delivery. This novel LNP demonstrated substantially improved in vivo ... -
Integrated LNP Composition and Ligand Targeting Dramatically Enhances Pancreatic Beta Cell-Directed RNA Delivery
ACS Nano USA Overview Engineering lipid nanoparticles (LNPs) through integrated compositional and ligand targeting dramatically enhances pancreatic beta cell-directed RNA delivery. Systematically varying the species and molar ratios of t... -
RNA Therapeutics Advance with Delivery Challenges: mRNA Vaccines, siRNAs, and ASOs Drive Disease Treatment
Facebook (Ambry Genetics) USA Overview Recent publications highlight the profound impact of RNA-based therapeutic modalities, including mRNA vaccines, siRNAs, and ASOs, in treating viral infections, genetic disorders, and cancer. However...
